We are live on ! Find out more
Natixis Advisors

Natixis Advisors Portfolio holdings

AUM $71.9B
1-Year Est. Return 28.03%
This Fund
S&P 500
This Quarter Est. Return
+1.46%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$6.68B
AUM Growth
+$582M
Cap. Flow
+$535M
Cap. Flow %
8%
Top 10 Hldgs %
12.65%
Holding
1,053
New
75
Increased
598
Reduced
299
Closed
81

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$24.3M
2
ACN icon
Accenture
ACN
+$21.8M
3
HON icon
Honeywell
HON
+$21.1M
4
JPM icon
JPMorgan Chase
JPM
+$20.4M
5
GE icon
GE Aerospace
GE
+$19.6M

Sector Composition

Rank Sector Weight
1 Financials 14.16%
2 Technology 14.03%
3 Healthcare 12.2%
4 Industrials 10.96%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
51
Intel
INTC
$466B
$24.4M 0.37%
754,602
+64,766
+9% +$1.99M
TRV icon
52
Travelers Companies
TRV
$80.8B
$24.3M 0.36%
208,135
+53,715
+35% +$5.86M
VAR
53
DELISTED
Varian Medical Systems, Inc.
VAR
$23.8M 0.36%
339,439
+26,269
+8% +$1.78M
CVS icon
54
CVS Health
CVS
$137B
$23.8M 0.36%
228,979
+29,565
+15% +$2.87M
C icon
55
Citigroup
C
$222B
$23.7M 0.35%
567,496
+66,034
+13% +$2.76M
HD icon
56
Home Depot
HD
$332B
$23.7M 0.35%
177,285
-2,167
-1% -$270K
VXUS icon
57
Vanguard Total International Stock ETF
VXUS
$153B
$23.4M 0.35%
521,275
+10,110
+2% +$431K
WBA
58
DELISTED
Walgreens Boots Alliance
WBA
$22.9M 0.34%
271,618
+130,726
+93% +$10.4M
TMO icon
59
Thermo Fisher Scientific
TMO
$211B
$22.4M 0.34%
158,297
+21,998
+16% +$2.95M
TSM icon
60
TSMC
TSM
$2.09T
$22.1M 0.33%
841,660
+114,709
+16% +$2.68M
GS icon
61
Goldman Sachs
GS
$313B
$21.9M 0.33%
139,346
+24,059
+21% +$3.72M
ELV icon
62
Elevance Health
ELV
$81.9B
$21.8M 0.33%
156,511
+101,608
+185% +$13.6M
LKQ icon
63
LKQ Corp
LKQ
$6.58B
$21.5M 0.32%
672,342
+291,898
+77% +$8.14M
AXP icon
64
American Express
AXP
$223B
$21.4M 0.32%
348,059
+42,456
+14% +$2.47M
PYPL icon
65
PayPal
PYPL
$49.5B
$21.3M 0.32%
551,260
+200,023
+57% +$7.23M
CERN
66
DELISTED
Cerner Corp
CERN
$20.9M 0.31%
394,500
+133,816
+51% +$7.29M
SNY icon
67
Sanofi
SNY
$104B
$20.3M 0.3%
505,424
+216,956
+75% +$8.72M
RTX icon
68
RTX Corp
RTX
$287B
$19.5M 0.29%
309,092
-24,302
-7% -$1.41M
ABBV icon
69
AbbVie
ABBV
$458B
$18.9M 0.28%
330,046
+182,413
+124% +$10.2M
ADP icon
70
Automatic Data Processing
ADP
$100B
$18.8M 0.28%
209,131
+37,254
+22% +$3.12M
VUG icon
71
Vanguard Growth ETF
VUG
$216B
$18.6M 0.28%
1,050,414
-1,574,232
-60% -$26.4M
AIG icon
72
American International
AIG
$41.9B
$18.6M 0.28%
344,220
+18,164
+6% +$981K
PPG icon
73
PPG Industries
PPG
$25.9B
$18.6M 0.28%
166,666
+19,218
+13% +$1.89M
AVGO icon
74
Broadcom
AVGO
$1.82T
$18.6M 0.28%
+1,202,100
New +$16.3M
HCA icon
75
HCA Healthcare
HCA
$84.8B
$18.4M 0.28%
235,558
+79,775
+51% +$5.57M

Similar funds

Natixis Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Natixis Advisors held 1,053 positions worth $6.68B, up 9.5% from $6.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Natixis Advisors deployed $535M of net new capital in Q1 2016, opening 75 new positions and adding to 598 existing holdings. Its largest new stake was Broadcom: 1,202,100 shares worth $18.6M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Growth ETF, an estimated $26.4M trimmed.

  • Natixis Advisors's largest Q1 2016 buy was Broadcom: 1,202,100 shares worth $18.6M.
  • Natixis Advisors added most to Johnson & Johnson in Q1 2016, an estimated $24.3M increase.
  • Natixis Advisors's biggest Q1 2016 reduction was Vanguard Growth ETF, cutting an estimated $26.4M.
  • Natixis Advisors fully exited Factset in Q1 2016, selling an estimated $20.5M.
  • Natixis Advisors's ten largest holdings make up 13% of its $6.68B portfolio in Q1 2016.
  • Natixis Advisors opened 75 new positions and closed 81 in Q1 2016.
  • Natixis Advisors's portfolio value rose 9.5% quarter-over-quarter to $6.68B.

Based on Natixis Advisors's 13F filing for Q1 2016, filed 6 May 2016.